New hair loss pill shows promise in early trial
NCT ID NCT06527365
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 38 times
Summary
This study tests an experimental oral drug called VDPHL01 for people with mild to moderate pattern baldness (androgenetic alopecia). About 70 men and women aged 18-65 will take the pill daily for 12 months to see if it safely increases hair count and improves appearance. The drug works by blocking hormones that cause hair loss, but it is not a cure—treatment must continue to maintain results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
01
San Diego, California, 92123, United States
-
02
South Jordan, Utah, 84095, United States
-
03
Hackensack, New Jersey, 07601, United States
-
04
New Albany, Indiana, 47150, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.